In March 2025, Japan’s Ministry of Health, Labour and Welfare has approved the marketing and manufacturing of Dupixent ...

Gabapentinoid use in patients with chronic obstructive pulmonary disease (COPD) was associated with a higher risk for severe exacerbations, a population-based cohort study from Canada indicated. Among ...

Your patients with chronic obstructive pulmonary disease (COPD) may need help not just coping with their condition but also managing it in their workplace. The symptoms of COPD, a lung and airway ...

It seems patient satisfaction is low when it comes to their chronic obstructive pulmonary disease (COPD) treatment, according to a recent report out from consultancy Phreesia Life Sciences. When ...

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)-- Patients with chronic obstructive pulmonary disease (COPD) face significant challenges, but conversations with healthcare providers can play a ...

Please provide your email address to receive an email when new articles are posted on . All-cause mortality in COPD patients was “strongly predicted” by diffusing capacity of the lung for carbon ...

Researchers explained that educational level, duration of disease, and inhaler type may affect adherence in patients with chronic obstructive pulmonary disease (COPD). Most patients with chronic ...

If you or someone close to you suffers from chronic shortness of breath, persistent cough, and reduced physical fitness, there is a chance it may be COPD. This is a serious lung disease affecting ...

Switching from a metered-dose to a dry-powder inhaler after a formulary change increased emergency department visits and hospitalizations in people with COPD or asthma. The absolute changes in risk ...